Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
8,047,184
-
Share change
-
+8,047,065
-
Total reported value
-
$70,171,000
-
Price per share
-
$8.72
-
Number of holders
-
19
-
Value change
-
+$70,170,000
-
Number of buys
-
18
Institutional Holders of AGILE THERAPEUTICS INC - COM (AGRX) as of Q2 2014
As of 30 Jun 2014,
AGILE THERAPEUTICS INC - COM (AGRX) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,047,184 shares.
The largest 10 holders included
INVESTOR AB, Aisling Capital LLC, ADAGE CAPITAL PARTNERS GP LLC, ROYCE & ASSOCIATES LLC, Alyeska Investment Group, L.P., Cormorant Asset Management, LLC, MILLENNIUM MANAGEMENT LLC, Visium Asset Management, LP, DEERFIELD MANAGEMENT CO, and DEUTSCHE BANK AG\.
This page lists
19
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.